Ocugen, Inc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.About OCGN
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN.
CEOShankar Musunuri
CEOShankar Musunuri
Employees95
Employees95
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2013
Founded2013
Employees95
Employees95
OCGN Key Statistics
Market cap360.73M
Market cap360.73M
Price-Earnings ratio-5.35
Price-Earnings ratio-5.35
Dividend yield—
Dividend yield—
Average volume3.89M
Average volume3.89M
High today$1.27
High today$1.27
Low today$1.15
Low today$1.15
Open price$1.21
Open price$1.21
Volume4.41M
Volume4.41M
52 Week high$1.90
52 Week high$1.90
52 Week low$0.515
52 Week low$0.515
Stock Snapshot
The current Ocugen, Inc(OCGN) stock price is $1.16, with a market capitalization of 360.73M. The stock trades at a price-to-earnings (P/E) ratio of -5.35.
As of 2025-11-18, Ocugen, Inc(OCGN) stock has fluctuated between $1.15 and $1.27. The current price stands at $1.16, placing the stock +1.3% above today's low and -8.7% off the high.
The Ocugen, Inc(OCGN)'s current trading volume is 4.41M, compared to an average daily volume of 3.89M.
In the last year, Ocugen, Inc(OCGN) shares hit a 52-week high of $1.90 and a 52-week low of $0.52.
In the last year, Ocugen, Inc(OCGN) shares hit a 52-week high of $1.90 and a 52-week low of $0.52.
People also own
Based on the portfolios of people who own OCGN. This list is generated using Robinhood data, and it’s not a recommendation.